Table:
begin	end	state
1	34	cytoplasmic
35	52	transmembrane
53	73	non-cytoplasmic
74	92	transmembrane
93	102	cytoplasmic
103	130	transmembrane
131	186	non-cytoplasmic
187	208	transmembrane
209	250	cytoplasmic
251	270	transmembrane
271	289	non-cytoplasmic
290	313	transmembrane
314	324	cytoplasmic
325	343	transmembrane
344	348	non-cytoplasmic
349	372	transmembrane
373	383	cytoplasmic
384	407	transmembrane
408	413	non-cytoplasmic
414	435	transmembrane
436	445	cytoplasmic

Input:
>Pf6N2E2_5056 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_5056
MIPSQSSRLATGLSASTGGVGDKIRGAMTVGKTRWGMLALVFFATTLNYIDRAALGVMQP
ILAKEMSWTAMDYANINFWFQVGYAVGFVLQGRLIDRIGVKRVFFCAVLLWSLATGAHGL
ATSAVGFMVCRFILGLTEAANYPACVKTTRLWFPAGERAVATGIFNAGTNVGAMFTPMLL
PLVLHVWGWQAAFLCMAALGGIWLVFWGLKYFNPEDHPTVKQSELDYIQAQDEPDQVRVP
FSRILRMRGTWAFALAYSITAPVFWFYLYWLPPFLNQQYNLGINVTQMGIPLIIIYLTAD
FGSVGGGILSSFLIGRGLDPIKARLVSMLLFACCIIGVIMAAGASNLWMAVFAISLAIGA
HQAWTANIWSLVMDYTPKHMMSTVFGFGGMCAAIGGMFMTQLVGHILTVTNNNYTVLFTL
IPAMYFTALIWLYFMAPRKVPTLEN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server